Po1011 Statin’S Prescription In Primary Prevention: A Clinical Audit In General Practice

Conference: 
Author(s): 
Rosa Avino, Claudia Prevedello, Guido Fruet, Antonella Fruet e Eduino Bonincontro
Text: 
BACKGROUND Cardiovascular disease due to atherosclerosis and to thrombosis is the main cause of premature death and disability in Europe. Causes are multifactorial and dyslipidaemias represents one of these. Lipid-lowering treatments, like Statins, are prescribed according to patient’s cardiovascular risk estimation. This Audit involved 4 Italian General Practitioners (GPs) working in the North of Italy. The study analysed a group of patients on Statins and set a shared modification in the way GPs will manage patients with dyslipidaemias for a six months interval. The study was prepared by Dr Rosa Avino at the end of her vocational training in General Practice.
METHODS Data analysed were collected from Millewin, the electronic medical record used by the GPs involved. There were done 4 data mining and each GP received an envelope with 8 documents concerning the latest revisions on the management of patients with dyslipidaemias. GPs used this supporting material for the six months to go, as expected.
RESULTS The first data mining collected 44 patients on Statins, according to the criteria selected. For all patients there were no data recorded about cardiovascular risk estimation. This was the main point to work on. After six months It was done a new extraction and data of 5 patients on a new therapy with Statins were collected. For all of them was recorded cardiovascular risk rate. Two more data collections were done. One to evaluate for how many patients GPs recorded the cardiovascular risk rate during the six months. There were collected data of 125 patients. The second to evaluate if there were patients with high cholesterol levels (>280mg/dl) not on Statins. Data of 35 patients were analysed.
CONCLUSIONS There are many documents to manage patients with dyslipidaemias (Guidelines, Cardiovascular risk estimation cards, Italian AIFA prescription annotations). This background material can be used in the daily clinical practice efficiently. After only six months, it was possible to observe that a structured and shared management of the patients could be strongly valuable in order to appropriateness.
Literature: 
PO1011 STATIN’S PRESCRIPTION IN PRIMARY PREVENTION: A CLINICAL AUDIT IN GENERAL PRACTICE
Keywords: 
statin, cholesterol, primary prevention, audit, cardiovascular risk